MRK logo

MRK
Merck & Co Inc

25,747
Mkt Cap
$300.2B
Volume
9.71M
52W High
$125.14
52W Low
$73.31
PE Ratio
16.69
MRK Fundamentals
Price
$121.42
Prev Close
$122.68
Open
$122.96
50D MA
$118.61
Beta
0.32
Avg. Volume
10.31M
EPS (Annual)
$7.28
P/B
5.71
Rev/Employee
$865,680.00
$299,786.82
Loading...
Loading...
News
all
press releases
Ritholtz Wealth Management Purchases 10,305 Shares of Merck & Co., Inc. $MRK
Ritholtz Wealth Management boosted its position in Merck & Co., Inc. (NYSE:MRK - Free Report) by 38.3% in the fourth quarter, according to its most recent filing with the Securities and Exchange...
MarketBeat·1h ago
News Placeholder
More News
News Placeholder
Massachusetts Financial Services Co. MA Sells 3,132,999 Shares of Merck & Co., Inc. $MRK
Massachusetts Financial Services Co. MA lessened its holdings in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 41.5% during the 4th quarter, according to the company in its most recent...
MarketBeat·1h ago
News Placeholder
Merck & Co., Inc. $MRK Shares Purchased by Choreo LLC
Choreo LLC boosted its holdings in Merck & Co., Inc. (NYSE:MRK - Free Report) by 7.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund...
MarketBeat·3h ago
News Placeholder
Carnegie Investment Counsel Grows Stock Position in Merck & Co., Inc. $MRK
Carnegie Investment Counsel raised its stake in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 15.8% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 86,715 shares of the company's stock after buying an additional 11,849 shares during the period...
MarketBeat·3h ago
News Placeholder
Prime Capital Investment Advisors LLC Sells 20,072 Shares of Merck & Co., Inc. $MRK
Prime Capital Investment Advisors LLC trimmed its holdings in Merck & Co., Inc. (NYSE:MRK - Free Report) by 37.1% during the fourth quarter, according to its most recent 13F filing with the...
MarketBeat·1d ago
News Placeholder
Merck & Co., Inc. $MRK Position Lessened by Cantor Fitzgerald Investment Advisors L.P.
Cantor Fitzgerald Investment Advisors L.P. trimmed its position in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 21.5% in the 4th quarter, according to the company in its most recent Form...
MarketBeat·1d ago
News Placeholder
Bartlett & CO. Wealth Management LLC Has $13.24 Million Position in Merck & Co., Inc. $MRK
Bartlett & CO. Wealth Management LLC trimmed its holdings in Merck & Co., Inc. (NYSE:MRK - Free Report) by 6.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 124,785 shares of the company's stock afte...
MarketBeat·1d ago
News Placeholder
Bar Harbor Wealth Management Has $18.11 Million Stock Holdings in Merck & Co., Inc. $MRK
Bar Harbor Wealth Management increased its stake in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 7.2% in the fourth quarter, according to the company in its most recent filing with the...
MarketBeat·1d ago
News Placeholder
Terns Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Terns Pharmaceuticals, Inc. - TERN
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Terns Pharmaceuticals, Inc. (NasdaqGS: TERN) to...
Business Wire·2d ago
News Placeholder
BMY Gains 10% Year to Date: Should You Buy, Sell or Hold the Stock?
BMY stock jumps 10% in a month as growth drugs power revenues, but generic erosion and 2026 sales outlook keep investors cautious.
Zacks·2d ago
<
1
2
...
>

Latest MRK News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.